# SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions

> **NCT03606148** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 170 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** SurePathTM

## Key facts

- **NCT ID:** NCT03606148
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-17
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606148, "SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03606148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*